Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to -$53412.5.

  • Legend Biotech's EPS (Basic) rose 7613.25% to -$53412.5 in Q3 2025 from the same period last year, while for Sep 2025 it was -$53412.5, marking a year-over-year increase of 7613.25%. This contributed to the annual value of -$0.48 for FY2024, which is 6734.69% up from last year.
  • Legend Biotech's EPS (Basic) amounted to -$53412.5 in Q3 2025, which was up 7613.25% from -$200348.4 recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's EPS (Basic) peaked at -$0.1 during Q1 2022, and registered a low of -$948228.6 during Q2 2024.
  • Its 4-year average for EPS (Basic) is -$142577.9, with a median of -$0.43 in 2021.
  • As far as peak fluctuations go, Legend Biotech's EPS (Basic) tumbled by 7091.96% in 2021, and later skyrocketed by 7887.13% in 2025.
  • Over the past 4 years, Legend Biotech's EPS (Basic) (Quarter) stood at -$0.31 in 2021, then tumbled by 36.23% to -$0.43 in 2022, then crashed by 52388256.8% to -$223787.5 in 2024, then soared by 76.13% to -$53412.5 in 2025.
  • Its EPS (Basic) stands at -$53412.5 for Q3 2025, versus -$200348.4 for Q2 2025 and -$223787.5 for Q3 2024.